Genome-Based Therapeutics: Targeted Drug Discovery and Development
Publisher: National Academies Press 2012
Number of pages: 89
Objectives: To examine the impact of and investment in genetic and genomic technologies and data in drug discovery and development; To examine and discuss the challenges for incorporating genomic technologies into drug development and to explore solutions to remedy those challenges; To discuss and explore how innovative, novel, and global partnerships between academia, industry, foundations, and government can enable the use of genomic information for more efficient and effective drug discovery and development programs.
Home page url
Download or read it online for free here:
by Alfred N. Martin - Lea & Febiger
This book provides an introduction to the physiochemical and mathematical principles underlying the practice of pharmacy. The emphasis on new dosage forms and controlled delivery systems, problems and worked examples are some of the features.
by Wendy L Bennett, et al. - AHRQ
Given the number of medications available for type 2 diabetes mellitus, clinicians and patients need information about their effectiveness to make informed choices. The objective of this review was to summarize the benefits and harms of medications.
- International Agency for Research on Cancer
This volume provides an assessment of the carcinogenicity of 14 drugs and herbal products. The authors relied on epidemiological studies to evaluate the carcinogenic hazard to humans exposed to the drugs digoxin, pioglitazone and hydrochlorothiazide.
by J. Eric McDuffie (ed.) - InTech
Because the incidence of neurobehavioral hazards and risks of exogenous compounds remain subject matter of interest, predictive tools have evolved, including novel translational in vitro models, biomarkers, newer epidemiological research tools, etc.